HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of ScheduleMorningStar·Jul 1 at 12:20 PMBEAT-4.37%
HeartBeam (NASDAQ: BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Studybusinessinsider·Jun 30 at 12:45 PMBEAT-4.37%
HeartBeam shares are trading higher after the company announced completion of patient enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection.benzinga_article·Jun 30 at 10:31 AMBEAT-4.37%
HeartBeam completes enrollment in ALIGN-ACS pilot study for heart attack detection ahead of schedulePUBT·Jun 30 at 06:01 AMBEAT-4.37%
HeartBeam (NASDAQ: BEAT) Reorganizes to Accelerate Global Commercialization Strategybusinessinsider·Jun 25 at 01:30 PMBEAT-4.37%
HeartBeam CEO Robert Eno shifts to consulting role as founder Vajdic, chairman Ferrari lead teamsPUBT·Jun 24 at 04:32 PMBEAT-4.37%
HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership TransitionUnusual Whales·Jun 24 at 03:12 PMBEAT-4.37%
HeartBeam shifts strategy to license 3D ECG platform to partners to drive global adoptionPUBT·Jun 24 at 03:07 PMBEAT-4.37%
HeartBeam grants President Branislav Vajdic 2,800,000 performance-based RSUsPUBT·Jun 22 at 03:17 PMBEAT-4.37%
Crypto Market Cap Slips as SpaceX IPO Rotates Capital Into StocksCoinLive·Jun 16 at 01:44 AMBTC-0.94%BEAT-4.37%
